Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (628)
- Volume 17, 2024 (7)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
- 628 records -
Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways
Lin H, Ni L, Phuong C, Hong JC
Pharmacogenomics and Personalized Medicine 2024, 17:65-76
Published Date: 13 February 2024
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL
Pharmacogenomics and Personalized Medicine 2024, 17:53-64
Published Date: 3 February 2024
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2024, 17:51-52
Published Date: 30 January 2024
The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period
Lilic J, Marjanovic VG, Budic I, Stefanovic N, Stokanovic D, Marjanovic GT, Jevtovic-Stoimenov T, Golubovic M, Zecevic M, Velickovic-Radovanovic R
Pharmacogenomics and Personalized Medicine 2024, 17:41-49
Published Date: 30 January 2024
FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults
Zhang M, Chen F, Feng S, Liu X, Wang Z, Shen N, Meng L, Zhu D, Zhu Z
Pharmacogenomics and Personalized Medicine 2024, 17:27-40
Published Date: 19 January 2024
Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene
Wang C, Deng X, Li L, Li M
Pharmacogenomics and Personalized Medicine 2024, 17:13-26
Published Date: 9 January 2024
circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer
Zhou H, Cui X, Zhu L, Xu Z, Wang Z, Shao J
Pharmacogenomics and Personalized Medicine 2024, 17:1-11
Published Date: 5 January 2024
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer [Corrigendum]
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:1149-1150
Published Date: 29 December 2023
Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]
López López-Cepero M, Obrador de Hevia A, Guillot Morales M
Pharmacogenomics and Personalized Medicine 2023, 16:1145-1147
Published Date: 28 December 2023
Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer
Han W, Li C, Wang Y, Huo B, Li W, Shi W
Pharmacogenomics and Personalized Medicine 2023, 16:1127-1143
Published Date: 23 December 2023
BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer
Luo H, Luo J, Ding N, Zhang T, He Y
Pharmacogenomics and Personalized Medicine 2023, 16:1109-1126
Published Date: 22 December 2023
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
Kolli P, Kelley G, Rosales M, Faden J, Serdenes R
Pharmacogenomics and Personalized Medicine 2023, 16:1097-1108
Published Date: 21 December 2023
A Case of Floating-Harbor Syndrome with “Growth and Language Development Delay” as Its Clinical Manifestation
Yang YC, Tang Q, Yan LJ, Zhang SB, Ye XM, Gong D, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:1091-1096
Published Date: 15 December 2023
Circ_0000140 Alters miR-527/SLC7A11-Mediated Ferroptosis to Influence Oral Squamous Cell Carcinoma Cell Resistance to DDP
Ma Y, Gao J, Guo H
Pharmacogenomics and Personalized Medicine 2023, 16:1079-1089
Published Date: 13 December 2023
A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment
Zhou M, Wang W, Weng J, Lai Z
Pharmacogenomics and Personalized Medicine 2023, 16:1067-1077
Published Date: 6 December 2023
Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis
Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F
Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066
Published Date: 5 December 2023
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023
Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
Meng L, Cao J, Kang L, Xu G, Yuan DW, Li K, Zhu K
Pharmacogenomics and Personalized Medicine 2023, 16:1027-1039
Published Date: 28 November 2023
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
Huang R, Zhang YT, Lin Y, Pang RL, Yang Z, Zhao WH
Pharmacogenomics and Personalized Medicine 2023, 16:1011-1026
Published Date: 11 November 2023
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao H, Li H
Pharmacogenomics and Personalized Medicine 2023, 16:991-1009
Published Date: 9 November 2023
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K, Vogel B, Mehran R
Pharmacogenomics and Personalized Medicine 2023, 16:973-990
Published Date: 3 November 2023
Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma
Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:959-972
Published Date: 4 November 2023
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population
Dai J, Zhang S, Shi Y, Xu J, Liu W, Yang J, Shi L, Yan Z, Li C
Pharmacogenomics and Personalized Medicine 2023, 16:933-948
Published Date: 30 October 2023
Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
Yuan H, Wang C, Liu L, Wang C, Zhang Z, Qu S
Pharmacogenomics and Personalized Medicine 2023, 16:925-932
Published Date: 28 October 2023
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z
Pharmacogenomics and Personalized Medicine 2023, 16:913-924
Published Date: 24 October 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]
Furqoni AH, Fajarwati I, Poetranto AL
Pharmacogenomics and Personalized Medicine 2023, 16:911-912
Published Date: 25 October 2023
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
Mouhrach I, Bouguenouch L, Kamal A, Meriame A, El Khorb N, El Azami El Idrissi M, Akoudad H, Bekkari H
Pharmacogenomics and Personalized Medicine 2023, 16:901-909
Published Date: 2 October 2023
Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Brown C, Wang J, Jiang H, Elias MF
Pharmacogenomics and Personalized Medicine 2023, 16:895-900
Published Date: 3 October 2023
Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
Rani DS, Kasala A, Dhandapany PS, Muthusami U, Kunnoth S, Rathinavel A, Ayapati DR, Thangaraj K
Pharmacogenomics and Personalized Medicine 2023, 16:883-893
Published Date: 20 September 2023
Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia
Albogami S
Pharmacogenomics and Personalized Medicine 2023, 16:859-882
Published Date: 15 September 2023
Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation
Jarrar Y, Abudahab S, Abdul-Wahab G, Zaiter D, Madani A, Abaalkhail SJ, Abulebdah D, Alhawari H, Musleh R, Lee SJ
Pharmacogenomics and Personalized Medicine 2023, 16:847-857
Published Date: 13 September 2023
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer
He H, Ma H, Chen Z, Chen J, Wu D, Lv X, Zhu J
Pharmacogenomics and Personalized Medicine 2023, 16:835-846
Published Date: 13 September 2023
Genetic Polymorphism of NQO1 Influences Susceptibility to Coronary Heart Disease in a Chinese Population: A Cross-Sectional Study and Meta-Anaylsis
Zhou YY, Sun JH, Wang L, Cheng YY
Pharmacogenomics and Personalized Medicine 2023, 16:825-833
Published Date: 11 September 2023
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant
Tang Q, Gong D, Ye XM, Xu JR, Yang YC, Yan LJ, Zou L, Wen XL
Pharmacogenomics and Personalized Medicine 2023, 16:817-823
Published Date: 8 September 2023
Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2
Xia S, Wang C
Pharmacogenomics and Personalized Medicine 2023, 16:805-815
Published Date: 4 September 2023
Pyroptosis and Inflammasome-Related Genes-NLRP3, NLRC4 and NLRP7 Polymorphisms Were Associated with Risk of Lung Cancer
Jing X, Yun Y, Ji X, Yang E, Li P
Pharmacogenomics and Personalized Medicine 2023, 16:795-804
Published Date: 25 August 2023
A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang
Huang J, Wu H, Zhao G, Ma Y, An Y, Sun L, Li F, Wang S
Pharmacogenomics and Personalized Medicine 2023, 16:785-794
Published Date: 23 August 2023
Clinical Characteristics and Novel ZEB2 Gene Mutation Analysis of Three Chinese Patients with Mowat-Wilson Syndrome
Han X, Zhang Q, Wang C, Han B
Pharmacogenomics and Personalized Medicine 2023, 16:777-783
Published Date: 23 August 2023
A Case Study and Literature Review of the Diagnosis of Danon Disease in Patients Presenting Only with Severe Cardiac Symptoms
Sun YQ, Lv Q, Chen D, Da Y, Zhao XY, Dong JZ
Pharmacogenomics and Personalized Medicine 2023, 16:767-775
Published Date: 17 August 2023
Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy
Wu J, Ren L, Huang X, Hu L, Zhang L, Xie D, Li Z, Han N, Huang S
Pharmacogenomics and Personalized Medicine 2023, 16:759-766
Published Date: 17 August 2023
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J
Pharmacogenomics and Personalized Medicine 2023, 16:747-758
Published Date: 9 August 2023
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2023, 16:739-746
Published Date: 27 July 2023
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
Coons JC, Empey PE
Pharmacogenomics and Personalized Medicine 2023, 16:729-737
Published Date: 11 July 2023
Association Between HTRA1, GAS6 and IFNGR2 Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population
Zhang F, Peng H, Fu C, Deng Y, Zhang M, Li W, Zhong J, Zhou Q, Huang L, Xiao S, Zhao J
Pharmacogenomics and Personalized Medicine 2023, 16:717-727
Published Date: 7 July 2023
Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
Hu M, Wei J, Hao J, Jin T, Li B
Pharmacogenomics and Personalized Medicine 2023, 16:707-715
Published Date: 3 July 2023
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
Bollinger A, Stäuble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML, Meyer zu Schwabedissen HE, Allemann SS
Pharmacogenomics and Personalized Medicine 2023, 16:693-706
Published Date: 3 July 2023
Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
Vears DF, Savulescu J, Christodoulou J, Wall M, Newson AJ
Pharmacogenomics and Personalized Medicine 2023, 16:681-691
Published Date: 1 July 2023
Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer
Wang B, Huang L, Ye S, Zheng Z, Liao S
Pharmacogenomics and Personalized Medicine 2023, 16:665-679
Published Date: 28 June 2023
A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
Eken E, Estores DS, Cicali EJ, Wiisanen KK, Johnson JA
Pharmacogenomics and Personalized Medicine 2023, 16:645-664
Published Date: 23 June 2023